HIV-1 Replication Benefits from the RNA Epitranscriptomic Code

被引:10
|
作者
Kong, Weili [1 ,3 ]
Rivera-Serrano, Efrain E. [2 ]
Neidleman, Jason A. [3 ]
Zhu, Jian [1 ]
机构
[1] Ohio State Univ, Dept Pathol, Wexner Med Ctr, Columbus, OH 43210 USA
[2] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA
[3] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA
基金
美国国家卫生研究院;
关键词
HIV-1; RNA methylation; Writers; Readers; MESSENGER-RNA; METHYLATION; BINDING; INHIBITION; PROTEINS; M(5)C; TAT;
D O I
10.1016/j.jmb.2019.09.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effects of RNA methylation on HIV-1 replication remain largely unknown. Recent studies have discovered new insights into the effect of 2'-O-methylation and 5-methylcytidine marks on the HIV-1 RNA genome. As so far, HIV-1 benefits from diverse RNA methylations through distinct mechanisms. In this review, we summarize the recent advances in this emerging field and discuss the role of RNA methylation writers and readers in HIV1 infection, which may help to find alternative strategies to control HIV-1 infection. (C) 2019 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5032 / 5038
页数:7
相关论文
共 50 条
  • [21] Cyclophilin A and HIV-1 replication
    Luban, J
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R758 - R758
  • [22] REGULATION OF REPLICATION OF HIV-1
    HASELTINE, WA
    CONTROL OF HUMAN RETROVIRUS GENE EXPRESSION, 1988, : 135 - 158
  • [23] Inhibition of HIV-1 replication with designed miRNAs expressed from RNA polymerase II promoters
    Lo, H-L
    Chang, T.
    Yam, P.
    Marcovecchio, P. M.
    Li, S.
    Zaia, J. A.
    Yee, J-K
    GENE THERAPY, 2007, 14 (21) : 1503 - 1512
  • [24] HIV-1 replication cycle
    Ferguson, MR
    Rojo, DR
    von Lindern, JJ
    O'Brien, WA
    CLINICS IN LABORATORY MEDICINE, 2002, 22 (03) : 611 - +
  • [25] Residual HIV-1 replication
    Pomerantz, RJ
    BIOMEDICINE & PHARMACOTHERAPY, 2000, 54 (01) : 13 - 15
  • [26] Inhibition of HIV-1 replication with designed miRNAs expressed from RNA polymerase II promoters
    H-L Lo
    T Chang
    P Yam
    P M Marcovecchio
    S Li
    J A Zaia
    J-K Yee
    Gene Therapy, 2007, 14 : 1503 - 1512
  • [27] The code structure of HIV-1
    Sato, Keiko
    Fushimi, Naoki
    Ohya, Masanori
    OPEN SYSTEMS & INFORMATION DYNAMICS, 2007, 14 (03): : 295 - 306
  • [28] Epitranscriptomic regulation of HIV-1 full-length RNA packaging (vol 50, pg 2302, 2022)
    Pereira-Montecinos, Camila
    Toro-Ascuy, Daniela
    Ananias-Saez, Catarina
    Gaete-Argel, Aracelly
    Rojas-Fuentes, Cecilia
    Riquelme-Barrios, Sebastian
    Rojas-Araya, Barbara
    Garcia-de-Gracia, Francisco
    Aguilera-Cortes, Paulina
    Chnaiderman, Jonas
    Acevedo, Monica L.
    Valiente-Echeverria, Fernando
    Soto-Rifo, Ricardo
    NUCLEIC ACIDS RESEARCH, 2022, 50 (08) : 4799 - 4799
  • [29] μ-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication
    Steele, AD
    Henderson, EE
    Rogers, TJ
    VIROLOGY, 2003, 309 (01) : 99 - 107
  • [30] SRSF1 RNA Recognition Motifs Are Strong Inhibitors of HIV-1 Replication
    Paz, Sean
    Lu, Michael L.
    Takata, Hiroshi
    Trautmann, Lydie
    Caputi, Massimo
    JOURNAL OF VIROLOGY, 2015, 89 (12) : 6275 - 6286